Skip to main content

BHC - Bausch Health Companies Inc.

This page shows which of the focused investors we track hold BHC and how their positions changed, so you can see how much conviction the group has in the stock.

In Q4 2021 it was held by 9 managers with an aggregate reported value of $1.59B, which is 0.12% of the combined portfolio.

As of Q4 2021, 9 tracked institutional managers held BHC (Bausch Health Companies Inc.) with an aggregate reported value of $1.59B — 0.12% of the combined AlphaBaseline portfolio.

Get email alerts when a tracked manager trades BHC — sign in or create a free account.

Source
Curated SEC 13F filings
Period
Q4 2021
Ticker
BHC

13F data is delayed and excludes shorts/non-13F assets.

Long holders

1Carl Icahn - Icahn Capital Management4.30%Add +1.8%34,721,118$958.65M
2ValueAct Capital - ValueAct Capital4.86%Reduce -13.0%15,616,761$431.18M
3Bill Miller - Miller Value Partners2.97%Add +1.6%3,043,128$84.02M
4Leon Cooperman - Leon Cooperman3.47%-2,500,000$69.03M
5Francis Chou - Chou Associates14.63%Reduce -48.8%765,000$21.12M
6Samantha McLemore - Patient Capital Management3.25%New290,300$8.02M
7Lee Ainslie - Maverick Capital0.00%Reduce -87.4%9,828$271K

Call holders — bullish via leverage

2 managers hold call options on BHC — a right to buy at strike. Notional value, not premium.

1Francis Chou - Chou Associates-600,000$16.57M
2Bill Miller - Miller Value Partners-20,000$552K
Loading holder history for BHC…